Author

Paul Pockros 1

1 Scripps Clinic,La Jolla,United States

DURABLE RESPONSE IN THE MARKERS OF CHOLESTASIS THROUGH 18 MONTHS OF OPEN-LABEL LONG-TERM SAFETY EXTENSION STUDY OF OBETICHOLIC ACID IN PRIMARY BILIARY CIRRHOSIS

Michael Trauner, Frederik Nevens, Pietro Andreone, Giuseppe Mazzella, Simone Strasser, Christopher L. Bowlus, Pietro Invernizzi, Joost P.H. Drenth, Paul Pockros, Jaroslaw Regula, Annarosa Floreani, Simon Hohenester, Velimir Luketic, Mitchell Shiffman, Karel van Erpecum, Victor Vargas, Catherine Vincent, Bettina E. Hansen;;

DURABLE RESPONSE IN THE MARKERS OF CHOLESTASIS THROUGH 24 MONTHS OF OPEN-LABEL EXTENSION STUDY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS

Michael Trauner, Frederik Nevens, Pietro Andreone, Giuseppe Mazzella, Simone Strasser, Pietro Invernizzi, Joost P.H. Drenth, Paul Pockros, Jaroslaw Regula, Annarosa Floreani, Simon Hohenester, Velimir Luketic, Mitchell Shiffman, Karel van Erpecum, Victor Vargas, Catherine Vincent, Bettina E. Hansen, Christopher L. Bowlus;;

SUSTAINED VIROLOGIC RESPONSE RATE OF 96% IN HCV GENOTYPE 1A-INFECTED PATIENTS TREATED WITH OMBITASVIR/PARITAPREVIR/R AND DASABUVIR WITH RIBAVIRIN

Heiner Wedemeyer, Paul Pockros, Samuel S. Lee, Edward Gane, Christophe Moreno, Simone Strasser, Victor De Ledinghen, Andreas Maieron, Wangang Xie, Roger Trinh, Yan Luo, Fernando Tatsch, Vinod Rustgi

TREATMENT WITH OBETICHOLIC ACID IN PATIENTS WITH NASH DOES NOT SHOW INCREASED MARKERS OF LIVER TOXICITY BASED ON EVALUATION OF DRUG-INDUCED SERIOUS HEPATOTOXICITY (EDISH)

Arun J Sanyal, Paul Pockros, Amrik Shah, Reshma Shringarpure, David Shapiro, Aldo Trylesinski, Leigh MacConell

Item 1 - 4 / 4
1